These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

217 related items for PubMed ID: 5600100

  • 21. The impact of diuretics on chronic liver disease.
    Steigmann F, Mejicano R.
    Am J Gastroenterol; 1969 Jul; 52(1):37-44. PubMed ID: 5796683
    [No Abstract] [Full Text] [Related]

  • 22. [Reasons for diuretic therapy of cirrhotic ascites].
    Parlapiano C, Paoletti V.
    Minerva Med; 1985 Nov 10; 76(43):2043-6. PubMed ID: 3934593
    [Abstract] [Full Text] [Related]

  • 23. [Concentration and reinfusion of ascitic fluid in liver cirrhosis].
    Mian G, Triolo L, Magris D, de Savorgnani MN, G'Agnolo B.
    Minerva Med; 1979 Sep 29; 70(42):2869-72. PubMed ID: 492554
    [Abstract] [Full Text] [Related]

  • 24. [Treatment of the edemato-ascitic syndrome in cirrhotics, role of amiloride (MK870)].
    Quinton A, Bancons J, Dubarry JJ.
    Bord Med; 1972 Oct 29; 5(16):2141-9. PubMed ID: 4640793
    [No Abstract] [Full Text] [Related]

  • 25. Renal effects of treatment with diuretics, octreotide or both, in non-azotemic cirrhotic patients with ascites.
    Kalambokis G, Economou M, Fotopoulos A, Bokharhii JA, Katsaraki A, Tsianos EV.
    Nephrol Dial Transplant; 2005 Aug 29; 20(8):1623-9. PubMed ID: 15886218
    [Abstract] [Full Text] [Related]

  • 26. The physiopathologic basis and limitations of treatment of cirrhotic edema with diuretics retaining potassium.
    Vesin P.
    Mater Med Pol; 1974 Aug 29; 6(3):199-201. PubMed ID: 4444335
    [No Abstract] [Full Text] [Related]

  • 27. [Diuretic therapy of Morgagni-Laennec's hepatic cirrhosis].
    De Martiis M, Fontana M, Venditti A.
    Clin Ter; 1972 Jun 30; 61(6):509-43. PubMed ID: 4669750
    [No Abstract] [Full Text] [Related]

  • 28. [Controlled clinical study of the effect of combined administration of ethacrynic acid and spironolactone in ascitic liver cirrhosis].
    Marra N, Micheli E, Spagnolo G.
    Clin Ter; 1979 Jul 31; 90(2):143-63. PubMed ID: 527296
    [No Abstract] [Full Text] [Related]

  • 29. [The place of diuretics in the treatment of cirrhotic ascites (apropos of 100 cases)].
    Levrat M, Truchot R.
    Rev Int Hepatol; 1965 Jul 31; 15(7):1159-85. PubMed ID: 5860912
    [No Abstract] [Full Text] [Related]

  • 30. [Effects of triamterene in combination with other diuretics in liver cirrhosis].
    Polli E.
    Minerva Med; 1963 Oct 10; 54(81 Suppl):3018-23. PubMed ID: 5877333
    [No Abstract] [Full Text] [Related]

  • 31. [Treatment of resistant ascites in cirrhotic patients].
    Aronoff A, Nayarai I.
    Union Med Can; 1974 Dec 10; 103(12):2081-9. PubMed ID: 4466021
    [No Abstract] [Full Text] [Related]

  • 32. Clinical study of verospirone and spironolactone.
    Gãbor G, Bekes M, Polãk G, Rausch J, Gulyãs A.
    Ther Hung; 1972 Dec 10; 20(1):36-45. PubMed ID: 5076528
    [No Abstract] [Full Text] [Related]

  • 33. [Triamterene in diuretic therapy of cirrhogenic ascites. Modifications of water-saline metabolism induced by its administration alone and in combination with fluprednisolone, methopyrone, mercaptomerine and benzothiazides].
    Ventura E, Loiodice L, Marani L.
    Minerva Med; 1963 Oct 10; 54(81 Suppl):3024-7. PubMed ID: 5877334
    [No Abstract] [Full Text] [Related]

  • 34. Amiloride (MK-870), a new antikaluretic diuretic. Comparison to other antikaluretic diuretics in patients with liver disease and ascites.
    Yamada S, Reynolds TB.
    Gastroenterology; 1970 Dec 10; 59(6):833-41. PubMed ID: 5486268
    [No Abstract] [Full Text] [Related]

  • 35. [Modern diuretics in the treatment of ascites caused by hepatic cirrhosis].
    Buligescu L, Candiori R.
    Med Interna (Bucur); 1970 May 10; 22(5):573-92. PubMed ID: 5426383
    [No Abstract] [Full Text] [Related]

  • 36. [Treatment of ascites in cirrhosis of the liver].
    Del Solar V, Lobo G, Varela N, Lehmann C.
    Rev Med Chil; 1965 Sep 10; 93(9):549-56. PubMed ID: 5888085
    [No Abstract] [Full Text] [Related]

  • 37. [INDICATIONS FOR THE TREATMENT OF ASCITIC CIRRHOSIS ACCORDING TO ITS CLINICAL FORMS].
    DUPUY R, VALLIN J, BOUTELLIER D, LODS JC.
    Bull Mem Soc Med Hop Paris; 1963 Nov 29; 114():1271-5. PubMed ID: 14100799
    [No Abstract] [Full Text] [Related]

  • 38. [RESULTS OF EXPERIMENTATION WITH A MICRONIZED ALDACTONE (8013 MCB) AND SULFONAMIDE DIURETIC (8093 CB) COMBINATION IN THE TREATMENT OF EDEMA].
    KISSEL P, DUREUX JB, SCHMITT J.
    Ann Med Nancy; 1963 Nov 29; 2():1543-50. PubMed ID: 14111518
    [No Abstract] [Full Text] [Related]

  • 39. Spironolactone and canrenoate: different antialdosteronic diuretic agents.
    Gentilini P.
    Hepatology; 1991 May 29; 13(5):999-1000. PubMed ID: 2030004
    [No Abstract] [Full Text] [Related]

  • 40. [STUDY OF THE ASSOCIATION OF A SALT DIURETIC AND A SPIRONOLACTONE. APROPOS OF 50 OBSERVATIONS].
    MOULINIER B, TETE R, COTTON J, GIRARD M.
    Lyon Med; 1964 Nov 22; 212():1183-206. PubMed ID: 14233311
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.